You are here

Actemra

Roche’s tocilizumab fails to achieve primary endpoints for Covid-19-related pneumonia

Roche’s tocilizumab fails to achieve primary endpoints for Covid-19-related pneumonia

Pharmaceutical Business Review

clinical trials

COVID-19 pneumonia

Flag link:

Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir

Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir

BioSpace

Gilead Sciences

clinical trials

COVID-19 pneumonia

Flag link:

Jury still out on IL-6 drugs in COVID-19 following preliminary trial results

Jury still out on IL-6 drugs in COVID-19 following preliminary trial results

Pharmaforum

clinical trials

Flag link:

Roche pleads for global harmony as it supercharges production of Actemra, COVID-19 tests

Roche pleads for global harmony as it supercharges production of Actemra, COVID-19 tests

Fierce Pharma

drug manufacturing

Flag link:

Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia

Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia

Motley Fool

clinical trials

Flag link:

All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them

All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them

Motley Fool

Gilead Sciences

hydroxychloroquine

Flag link:

Roche begins phase 3 trial of Actemra in COVID-19 pneumonia

Roche begins phase 3 trial of Actemra in COVID-19 pneumonia

Pharmaforum

clinical trials

Flag link:

China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines

China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines

Fierce Pharma

Flag link:

Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup

Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup

Endpoints

Flag link:

Roche's Child Arthritis Drug's New Formulation Gets FDA Nod

Roche's Child Arthritis Drug's New Formulation Gets FDA Nod

Yahoo/Zacks.com

systematic juvenile idiopathic arthritis

Flag link:

New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis

New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis

RAPS.org

giant cell arteritis

Flag link:

Could an old Roche arthritis med become a pioneering PAH treatment?

Could an old Roche arthritis med become a pioneering PAH treatment?

BioPharma Dive

pulmonary arterial hypertension

Flag link:

Roche’s Arthritis Blockbuster Holds Promise for Diabetes

Roche’s Arthritis Blockbuster Holds Promise for Diabetes

Bloomberg

type 1 diabetes

Flag link:

Abbott, Roche Issue Dueling Arthritis Drug Reports

Abbott, Roche Issue Dueling Arthritis Drug Reports

Investors.com

rheumatoid arthritis

Abbott Laboratories

Flag link:

Roche Scores Important Win With Actemra

Roche Scores Important Win With Actemra

Seeking Alpha

rheumatoid arthritis

Flag link:

Roche Wins Broader U.S. Approval for Actemra Arthritis Drug

Roche Wins Broader U.S. Approval for Actemra Arthritis Drug

Bloomberg

Flag link:

Roche seeks OK for juvenile Actemra use

Roche seeks OK for juvenile Actemra use

Fierce Pharma

juvenile arthritis

Flag link:

Roche Wins U.S. Approval for Arthritis Drug Actemra

Roche Wins U.S. Approval for Arthritis Drug Actemra

BusinessWeek

Flag link:

Roche's Actemra successful in arthritis study

Roche's Actemra successful in arthritis study

Reuters

Flag link:

Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission

Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission

Reuters

rheumatoid arthritis

Flag link:

Pages